This activity is supported in part by a medical education grant from Masimo and an unrestricted educational grant from Medtronic.
This program consists of 2 modules: Module 1 is the didactic component and offers 2 patient safety credits; Module 2 is... Read More +
The American Society of Anesthesiologists is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The American Society of Anesthesiologists designates this enduring material activity for a maximum of 6 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Maintenance of Certification in Anesthesiology® and MOCA® are registered certification marks of The American Board of Anesthesiology®. MOCA 2.0® is a trademark of the American Board of Anesthesiology®.
This activity offers up to 6 CME credits (2 patient safety credits for completion of module 1; 4 CME credits, and 4 MOCA part 4 QI points for completion of module 2), of which 2 credits contribute to the patient safety CME component of the American Board of Anesthesiology’s redesigned Maintenance of Certification in Anesthesiology® (MOCA®) program, known as MOCA 2.0®. Please consult the ABA website, www.theABA.org, for a list of all MOCA 2.0 requirements.
At the conclusion of this activity, participants will be able to:
Part I: Background on Opioids
Part II: Hospital Inpatient Opioid Overdose
Part III: Community Opioid Overdose
Part IV: The Impaired Practitioner
Disclosure Statement: The American Society of Anesthesiologists remains strongly committed to providing the best available evidence-based clinical information to participants of this educational activity and requires an open disclosure of any potential conflict of interest identified by our faculty members. It is not the intent of the American Society of Anesthesiologists to eliminate all situations of potential conflict of interest, but rather to enable those who are working with the American Society of Anesthesiologists to recognize situations that may be subject to question by others. All disclosed conflicts of interest are reviewed by the educational activity course director/chair to ensure that such situations are properly evaluated and, if necessary, resolved. The American Society of Anesthesiologists educational standards pertaining to conflict of interest are intended to maintain the professional autonomy of the clinical experts inherent in promoting a balanced presentation of science. Through our review process, all American Society of Anesthesiologists activities are ensured of independent, objective, scientifically balanced presentations of information. Disclosure of any or no relationships will be made available for all educational activities.
Disclosures: The following faculty and planning committee members have indicated that they have relationships with ineligible companies to disclose:
David Craig, PharmD
Meter Health – Consultant
Trevena – Consultant
Jeffrey Green, MD, MSHA, FASA
Cerus Corporation – Grant / Contract
La Jolla Pharmaceutical Company – Consultant
Medtronic – Consultant
Senthilkumar Sadhasivam, MD, MPH, MBA, FASA
NeurOptics – Consultant
The above financial relationships have been mitigated.
All other planners, faculty, and staff have reported no relevant financial relationships with ineligible companies to disclose.